| D a y L o g | |||||||||
| Monday | 4. apríla 2005 | ||||||||
| Act. No. | Activity | nb | Began | Ended | Length | prescribed | Bonus / Deficit | ||
| ideal | less | least | |||||||
| I | SL | F | 7 | 9.5 | 2.5 | 7 | 6 | 5.5 | 4.5 |
| II | EX | 0.75 | ms | ||||||
| III | MCh | 47 | 9.5 | 12.5 | 2.25 | 1.25 | -1 | ||
| II–III | M | 2.25 | 2 | NA | |||||
| IV | FL | 0.25 | ms | ||||||
| V | PrM | 0.25 | ms | ||||||
| VI | QU | 0.5 | ms | ||||||
| IV–VI | US | 1 | ms | ||||||
| VII | S1 | 4 | 2.75 | 2 | ms | ||||
| VIII | S2a | 1 | |||||||
| IX | FP | 48 | 10 | 25.25 | 7 | 2.5 | 4 | -4 | |
| X | FA | 2.5 | 4 | ||||||
| XI | F | 12.5 | 13.5 | 1 | 2.5 | 4 | |||
| XII | NCh | 49 | 13.5 | 16 | 2 | 2 | |||
| XIII | PrN | 0.25 | ms | ||||||
| XIV | NP | F | 16 | 17 | 1 | 0.75 | -0.25 | ||
| XII–XIV | N | 3 | 3 | NA | |||||
| XV | S2b | 3 | 2.75 | 2 | ms | ||||
| XVI | S3 | 1.5 | 3 | ||||||
| VII | S1 | 4 | 2.75 | 2 | -2 | ||||
| VIII + XV | S2 | 4 | 2.75 | 2 | -2 | ||||
| XVI | S3 | 1.5 | 3 | ||||||
| VII+VIII+XV | PS | 8 | 5.5 | 4 | -4 | ||||
| VII+VIII+XV+XVI | RS | 8 | 5.5 | 4 | -4 | ||||
| IX–XI | FS | 8 | 2.5 | 4 | -4 | ||||
| S | 7 | 9.5 | 7 | 5.5 | -2.5 | ||||
| XVIIa | ECh1 | 49 | 19.5 | 21.5 | 2 | 5 it. | -4 | ||
| XVIIb | ECh2 | na | ms | ||||||
| XVIIc | TXT | na | ok | ||||||
| XVIId | PRG | na | ms | ||||||
| XVII | ECh | 2 | 1.5 | -0.5 | |||||
| XVIIIa | EML1 | 17 | 17.25 | 0.25 | na | ok | |||
| XVIIIb | EML2 | 24.75 | 25 | 0.25 | na | ||||
| XIX | AL | 1.25 | 2.25 | 2.75 | |||||
| XVIII–XIX | Out | 0.5 | 1.25 | 2.25 | 2.75 | 0.75 | |||
| XX | JR | 0.25 | ms | ||||||
| XXI | PrB | ms | |||||||
| I + XIV | SLS | 3.5 | 7.75 | 6.75 | 6.25 | 4.25 | |||
| I | SL | 25.25 | 7 | 6 | 5.5 | ||||
| 10 | 10.75 | MCh | 4 | ok | |||||
| 10.75 | 14.75 | 15.25 | 17.25 | 19.5 | 21.5 | 24.8 | 25 | ||
| 14.75 | 15.25 | LT, DN: Wolfean Relapse continued after all… | -4 | -1 | -1 | ||||